Clinical trial of ethynodiol diacetate in a sequential oral contraceptive.
D001941:Breast Diseases / Q000139:chemically induced*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005040:Ethynodiol Diacetate / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000009:adverse effects; D008535:Megestrol / Q000009:adverse effects; D009277:Nandrolone / Q000009:adverse effects; D011247:Pregnancy; D011278:Pregnanes / Q000009:adverse effects; D011372:Progestins / Q000009:adverse effects
D003276:Contraceptives, Oral; D006908:Hydroxyprogesterones; D011278:Pregnanes; D011372:Progestins; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D009277:Nandrolone; D008535:Megestrol